Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of HDAC9 mRNA | decreases expression | 19933214
|
D012436 |
S-Adenosylmethionine |
S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of HDAC9 mRNA] | decreases reaction|increases expression | 18098314
|
D003997 |
Dicarbethoxydihydrocollidine |
Dicarbethoxydihydrocollidine results in increased expression of HDAC9 mRNA | increases expression | 18098314
|
D003997 |
Dicarbethoxydihydrocollidine |
S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of HDAC9 mRNA] | decreases reaction|increases expression | 18098314
|
C056507 |
gemcitabine |
gemcitabine results in increased expression of HDAC9 mRNA | increases expression | 17039268
|
D016685 |
Mitomycin |
HDAC9 protein affects the susceptibility to Mitomycin | affects response to substance | 16217747
|
D017239 |
Paclitaxel |
HDAC9 protein results in increased susceptibility to Paclitaxel | increases response to substance | 16734730
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of HDAC9 mRNA | increases expression | 16966095
|
D014284 |
Triiodothyronine |
Triiodothyronine results in increased expression of HDAC9 mRNA | increases expression | 17399805
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of HDAC9 mRNA | decreases expression | 19933214
|
D019772 |
Topotecan |
HDAC9 protein affects the susceptibility to Topotecan | affects response to substance | 16217747
|
C081489 |
valsartan |
valsartan inhibits the reaction [AGT protein results in increased expression of HDAC9 mRNA] | decreases reaction|increases expression | 19225232
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.04 | 15322242 14514962 11752688 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.57 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.92 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.12 | 17306315 16712894 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.08 | 11748828 |
MESH:D001321 |
Autistic Disorder |
|
S-Adenosylmethionine |
3.63 | 16917939 19056591 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.18 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.01 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.85 | 15746008 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.72 | 15867366 |
MESH:D001943 |
Breast Neoplasms |
|
gemcitabine |
2.07 | 18382427 17039268 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
2.07 | 18323546 18223236 16273361 16115903 16244791 18234424 15136595 11325840 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.07 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.91 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
3.38 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
3.38 | 17306315 15276417 16507464 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.41 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
7.36 | 18670907 16120746 18850075 |
MESH:D006332 |
Cardiomegaly |
|
valsartan |
7.36 | 19597038 |
MESH:D009202 |
Cardiomyopathies |
|
valsartan |
4.52 | 16247790 |
MESH:D002318 |
Cardiovascular Diseases |
|
valsartan |
4.39 | 11230374 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
3.08 | 19524636 20056578 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.29 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.15 | 15668235 8697196 16354765 15340226 12621046 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
2.44 | 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.18 | 14669216 17141729 |
MESH:D003324 |
Coronary Artery Disease |
|
valsartan |
3.94 | 17719468 |
MESH:D003384 |
Coxsackievirus Infections |
|
valsartan |
6.04 | 20392896 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 10048152 20055451 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
valsartan |
4.71 | 11508273 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
valsartan |
4.91 | 18630688 11427623 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.57 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.86 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.51 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.12 | 15322242 16714409 18230668 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.15 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
2.92 | 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.12 | 11564622 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.63 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.67 | 20067830 |
MESH:D005355 |
Fibrosis |
|
valsartan |
9.67 | 16893502 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.87 | 16452187 |
MESH:D015432 |
Glomerulonephritis, Membranoproliferative |
|
valsartan |
5.70 | 16928621 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.81 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.40 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
valsartan |
4.33 | 19027736 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.48 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.07 | 15340226 12621046 16120746 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.27 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.26 | 18606429 15340226 16354765 8697196 16959395 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.70 | 18850075 18670907 |
MESH:D006973 |
Hypertension |
|
valsartan |
5.70 | 20102058 18390891 18344623 10903974 16475468 12850387 11427623 12692753 |
MESH:D006974 |
Hypertension, Malignant |
|
valsartan |
6.63 | 11560862 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.08 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.92 | 12200463 12878042 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.48 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.87 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
valsartan |
6.87 | 12164870 16893502 10903974 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.97 | 17353645 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dicarbethoxydihydrocollidine |
5.32 | 16015684 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
S-Adenosylmethionine |
5.32 | 15983038 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
5.32 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
valsartan |
5.32 | 15504291 16872305 15619341 |
MESH:D008113 |
Liver Neoplasms |
|
Mitomycin |
7.83 | 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.83 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.83 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.19 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.26 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
2.34 | 17077188 19931552 17306315 15276417 16712894 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.34 | 19555203 11884234 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
4.21 | 14749477 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
3.65 | 12040289 12025231 16342250 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.65 | 16487513 19082730 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
3.78 | 14749477 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.13 | 12213967 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
3.30 | 15867366 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
2.56 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.84 | 20056578 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.37 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.23 | 12854658 |
MESH:D009447 |
Neuroblastoma |
|
Topotecan |
3.91 | 15176712 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
5.17 | 15867366 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
5.25 | 11161223 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
5.25 | 17306315 15276417 |
MESH:D010190 |
Pancreatic Neoplasms |
|
gemcitabine |
6.17 | 11504793 18383843 17440100 18992248 16929163 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Mitomycin |
6.17 | 15113037 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.47 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.72 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.38 | 11896295 11118676 11222880 11399792 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
3.48 | 16356831 17172428 17136230 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.48 | 16039940 |
MESH:D011507 |
Proteinuria |
|
valsartan |
5.00 | 12164870 17664856 18344623 |
MESH:D011658 |
Pulmonary Fibrosis |
|
valsartan |
3.86 | 17241526 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.00 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.79 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.79 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.90 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
2.44 | 18506536 18396642 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
5.01 | 16930453 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.12 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
2.55 | 16712894 11723127 17306315 16452187 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.90 | 11813266 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.62 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.81 | 12125929 |
MESH:D020257 |
Ventricular Remodeling |
|
valsartan |
5.89 | 19027736 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.47 | 15886252 |